Tag Archives: Adults

FDA Approves Ayvakit (avapritinib) for the Treatment of Adults with Unresectable or Metastatic PDGFRA Exon 18 Mutant Gastrointestinal Stromal Tumor

FDA Approves Ayvakit (avapritinib) for the Treatment of Adults with Unresectable or Metastatic PDGFRA Exon 18 Mutant Gastrointestinal Stromal Tumor Print this page CAMBRIDGE, Mass., Jan. 9, 2020 /PRNewswire/ — Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that the U.S. Food… Read More »

FDA Approves Cablivi (caplacizumab-yhdp) for Acquired Thrombotic Thrombocytopenic Purpura (aTTP) in Adults

FDA Approves Cablivi (caplacizumab-yhdp) for Acquired Thrombotic Thrombocytopenic Purpura (aTTP) in Adults Print this page February 6, 2019 — The U.S. Food and Drug Administration today approved Cablivi (caplacizumab-yhdp) injection, the first therapy specifically indicated, in combination with plasma exchange and immunosuppressive therapy, for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP),… Read More »

Can Young Adults Never Diagnosed With Hypertension Face an Increased Risk of Other Diseases?

Previous studies have linked high blood pressure and dementia risk. But a new study published in Neurology suggests that young adults with blood pressure (BP) levels above normal but not enough to be considered hypertensive are at an increased risk for brain shrinkage, which can lead to a decline in cognitive function and possibly dementia,… Read More »

Hard-to-Treat Hypertension Among Black Adults May Be Linked to Sleep Apnea

Black people are more likely to have hypertension than their white counterparts. Now, new findings published in the journal Circulation suggest that untreated sleep apnea that’s moderate or severe is associated with increased odds of resistant hypertension in African Americans, according to an article by American Heart Association News. Sleep apnea is a serious sleep… Read More »